Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Rare Disease Day on February 29 offers a chance to show solidarity with the estimated 300 million people living with rare dis…
Dowling manages logistics, which means getting products where they are needed. He holds himself accountable for environmental…
Dr. Brittany Clayborne travels the United States inspiring others to share their story. Here are the tips she offered at the …
With pro football fanfare, Uplifting Athletes will celebrate early career scientists later this week by awarding $20,000 gran…
Patients who manage chronic illnesses navigate the line between wanting to be self-sufficient and knowing when to reach out f…
Some patients still like to see a white coat, but the COVID-19 pandemic may have turned the tide toward more casual attire, l…
Eurordis, the European patient advocacy group, invites people around the world to take a photo that “visually expresses what …
Patient organizations have until February 18 to apply for CSL Behring’s Local Empowerment for Advocacy Development (LEAD) Gra…
The global celebration unites rare disease patients and their advocates on February 29. Find out how to show your support.
Americas
Asia Pacific
Middle East
Europe
